Study Collaboration Solution
Accelerate Startup and Improve Collaboration
Improve workflows across sites, sponsors, and CROs via a seamless solution that supports study startup and enrollment planning and tracking. Join the 225,000 researchers already using Advarra’s technology to collaborate on study startup across the globe.
We are Faster Together
Study startup is a relay race that requires smooth handoffs between stakeholders to move forward as efficiently and compliantly as possible. But sites often bear the burden of redundant requests and process. As the trusted technology provider for leading academic medical centers, cancer centers, site networks, and health systems, we’ve seen what sites can achieve when they’re enabled to collaborate across sponsors, CROs, and vendor partners.
When we remove barriers to visibility and communication that often occurs between site and sponsors, we can speed up study startup. Advarra helps to streamline handoffs for feasibility assessments, document exchange, training, and milestone tracking, making collaboration more seamless and less redundant for every stakeholder. Together, we’re making strides in study startup collaboration. We’re #FasterTogether.
AMR Saves Site Staff Time During Study Startup
Nancy Cleverley, SVP of Operations with The Alliance for Multispecialty Research (AMR), speaks to saving staff time with Advarra’s intuitive and engaging training solutions.
Velocity Clinical Research Accelerates Research with Advarra’s Technology
Chief Technology Officer Raghu Punnamraju showcases progress made in feasibility and scalability across Velocity Clinical Research’s global site network, in partnership with Advarra’s site technology solutions.
Yale Accelerates Study Activation Timelines with Advarra Technology
Research veteran Rhonda Paz reflects on achievements in study startup thanks to centralized processes and tandem activation workflows.
Velocity Clinical Research Delivers Industry-Leading Startup Timelines with Advarra Partnership
As SVP of Study Startup at Velocity, Erin Williams understands small optimizations can have a big impact on study startup. In this video, she reflects on improvements Velocity Clinical Research has made to activation timelines with the appropriate combination of people, process, and technology.
Yale Optimizes Operations Built on Advarra’s Technology Ecosystem
Brian Sevier, Chief Operations Officer for Yale’s Center of Clinical Investigation, speaks to startup efficiencies gained by integrating into existing site workflows.
The Future of Study Startup
Provide sites more flexibility, without sacrificing visibility for study teams like yours. How? Our unique vantage point in the industry enables us to go where other startup and investigator portals can’t reach.
Start enrolling sooner with the only site-sponsor collaboration solution giving you immediate visibility to help you hit every milestone on time, including ethics review.
- Allow sites to use their own organizational login to access the entire study startup workflow
- Guide site activation and track milestones across stakeholders, including real-time visibility into IRB status
- Deploy efficient, engaging, and compliant study training site staff will want to take
- Automate workflows with the strongest system integrations than any other solution
Why Research Leaders Trust Advarra
When Startup is Faster, Enrollment Starts Sooner
Improve Visibility
Lack of connectivity across stakeholders, systems, and spreadsheets requires too many manual updates, without real-time insight into true progress across sites and studies.
Reduce Tech Burden
Sites report setup and training on sponsor technology as very burdensome, creating the biggest challenge among all startup activities.
Optimize Enrollment Plans
Too often enrollment progress only begins after activation. How can enrollment planning and startup work in tandem to ensure sites are prepared and ready to execute the trial as soon as possible?
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
